Log In to Register
When and Where
  • 2/21/2023 1:00 PM EST
  • 2/21/2023 2:30 PM EST
  • Zoom

The Patent Litigation Committee and the ANDA & BPCIA Proceedings Subcommittee Present:
Section 112 Issues in ANDA and Biologics Litigation


Jenna Deneault, Counsel, Groombridge Wu

Jill Schmidt, Assistant General Counsel, Litigation, Genentech, Inc.
Laura Lydigsen, Partner, Crowell & Moring LLP
Hassen Sayeed, M.D., J.D., Partner, O’Melveny & Meyers LLP
Josephine Young, Partner, Groombridge Wu

With the Supreme Court poised to take up Section 112 issues, the panel will review the current state of section 112 issues in ANDA and biologics litigation, and discuss where we will go from here.

Private Practitioner Cost:
FCBA Member - Complimentary
Non-Member $175

Government/Academic/Retired/Student Cost:
FCBA Member - Complimentary 
Non-Member: $50

CLE Information:
FCBA is an approved provider with most states requiring CLE. Individual states have different approval guidelines and timeframes, and the FCBA cannot guarantee a state’s approval of CLE credit for any webcast or other program session. 

For information on CLE accreditation, please contact our CLE Manager at cle@fedcirbar.org.